United Therapeutics reported $461.9M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Amarin AMRN:US $ 94.63M 49.86M
Ardelyx ARDX:US $ 0.47M 0.56M
Baxter International BAX:US $ 3707M 193M
Bayer BAYN:GR € 14639M 3521M
Biocryst Pharmaceuticals BCRX:US $ 49.92M 2.76M
Biogen BIIB:US $ 2531.8M 202M
Biomarin Pharmaceutical BMRN:US $ 519.36M 69.55M
Emergent Biosolutions EBS:US $ 307.5M 415.7M
Esperion Therapeutics ESPR:US $ 18.84M 3.44M
Gilead Sciences GILD:US $ 6590M 654M
GlaxoSmithKline GSK:LN 9780M 253M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Insmed INSM:US $ 53.11M 3.02M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Johnson & Johnson JNJ:US $ 23426M 1378M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0.02M
Moderna Inc MRNA:US 6.07B 1.14B
Pfizer PFE:US $ 25661M 2026M
Ptc Therapeutics PTCT:US $ 148.74M 16.49M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Sangamo Biosciences SGMO:US $ 28.23M 0.24M
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
Seattle Genetics SGEN:US $ 426.46M 3.39M
Teva Pharmaceutical TEVA:IT 3.66B 439M
United Therapeutics UTHR:US $ 461.9M 46.7M
Vertex Pharmaceuticals VRTX:US $ 2097.5M 24.94M